Deniz, currently serving as currently serving as Chief Medical Officer, Global Head of Medical & Pharmacovigilance at GE Healthcare Lifesciences, played a key role in the filing and approval of multiple drugs and in-vivo diagnostics agents in several therapeutic areas of unmet need, including omalizumab for the treatment of asthma in the US and the EU.
Share
Download our apps
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.